Gene And Cell Therapy Products Community

 View Only
Back to discussions
Expand all | Collapse all

Novel Modalities Subgroup within the AAPS Therapeutic Product Immunogenicity community

  • 1.  Novel Modalities Subgroup within the AAPS Therapeutic Product Immunogenicity community

    Posted 05-08-2023 10:29

    Hello,

    Novel modalities pose unique considerations for the risk assessment and bioanalysis of immunogenicity. The goal of this working group is to provide a forum to discuss challenges and to share experiences. Modalities of interest include, but are not limited to:

    • Cellular therapies
    • Gene therapies
    • Liposomal delivery systems
    • Oligonucleotide
    • Complex biologics

    The group will tentatively meet on the second to last Monday of the month from 1 pm to 2pm. Interested members should contact Michael Swanson ([email protected]) or Kun Yang ([email protected]) with a preferred day of the week/time along with modalities of interest.

    Best,

    Michael and Kun



    ------------------------------
    Michael Swanson
    Associate Scientific Director
    Janssen
    Spring House PA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------


  • 2.  RE: Novel Modalities Subgroup within the AAPS Therapeutic Product Immunogenicity community

    Posted 05-09-2023 15:06

    Hi Mike and Kun
    I am interested in joining this group, please add me. My interests are in cell based NAB, potency assay and in biomarkers.

    Thanks
    Farhan



    ------------------------------
    Farhan Rizvi
    Senior Scientist
    KCAS Bioanalytical and Biomarker Services
    Olathe KS
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------

    Original Message